Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ad free!Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ad free today!Spring offer! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

Celltrion
Biotech
Topics

Advertisement

Celltrion

Share

Top Latest Popular

Celltrion takes over French health care firm Gifrer The Korea Times 04:02 Tue, 12 May

The Korea Times 04:02 Tue, 12 May

Celltrion buys France’s Gifrer to tap expanding biosimilar substitution market Korea Biomedical Review 05:56 Tue, 12 May

Korea Biomedical Review 05:56 Tue, 12 May

Celltrion’s Zymfentra sees 185% surge in US prescriptions The Korea Herald 03:36 Fri, 08 May

The Korea Herald 03:36 Fri, 08 May

Advertisement

Advertisement

Celltrion’s Vegzelma strengthens lead in Japan bevacizumab biosimilar market Korea Biomedical Review 05:53 Mon, 18 May

Korea Biomedical Review 05:53 Mon, 18 May

Celltrion acquires entire stake in French health care company Gifrer Yonhap News Agency 12:10 Tue, 12 May

Yonhap News Agency 12:10 Tue, 12 May

Celltrion buys France’s Gifrer to expand beyond biosimilars The Korea Herald 03:22 Tue, 12 May

The Korea Herald 03:22 Tue, 12 May

Advertisement

Advertisement

Latest

In the last month

Celltrion to issue bonus shares, repurchase stocks to boost shareholder value Yonhap News Agency 07:21 Thu, 21 May

Celltrion’s Vegzelma strengthens lead in Japan bevacizumab biosimilar market Korea Biomedical Review 05:53 Mon, 18 May

Analysts grow more bullish on Celltrion as margin expansion gains traction Korea Biomedical Review 01:08 Thu, 14 May

Celltrion acquires entire stake in French health care company Gifrer Yonhap News Agency 12:10 Tue, 12 May

Celltrion buys France’s Gifrer to tap expanding biosimilar substitution market Korea Biomedical Review 05:56 Tue, 12 May

Celltrion takes over French health care firm Gifrer The Korea Times 04:02 Tue, 12 May

Gifrer Acquisition To Boost Celltrion’s French Reach, Portfolio Scrip Pharma Intelligence 03:48 Tue, 12 May

Celltrion buys France’s Gifrer to expand beyond biosimilars The Korea Herald 03:22 Tue, 12 May

Spotlight On: Rituxan® (rituximab) / Truxima® (rituximab-abbs) / Ruxience® (rituximab-pvvr) / Riabni™ (rituximab-arrx) - May 2026 JD Supra 19:46 Mon, 11 May

Spotlight On: Biosimilar Litigations - May 2026 JD Supra 19:16 Mon, 11 May

Advertisement

Advertisement

Advertisement

About our Celltrion news

Latest news on Celltrion, a biopharmaceutical company headquartered in Incheon, South Korea.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Business Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna